Cas No.: 945245-82-9
PRODUCT INFORMATION
Description
REA (Cys-Arg-Glu-Ala-Gly-Arg-Lys-Ala-Cys) is a research peptide that can distinguish between different stages of tumor development in models. It specifically recognizes the lymphatics in premalignant lesions but does not bind to the lymphatic vessels of fully established tumor models, making it a valuable tool for studying the progression of tumor-associated lymphangiogenesis.
Molecular Weight
993.17
Purity
> 95%
Formula
C₃₇H₆₈N₁₆O₁₂S₂
Product Type
Targeting Peptide
Sequence
Cys-Arg-Glu-Ala-Gly-Arg-Lys-Ala-Cys
Form (20 deg.C)
Solid
Storage Condition
Store the product under the recommended conditions in the Certificate of Analysis (CoA).
For Research Use Only | Not For Clinical Use
Related products
- Cyclo(Arg-Gly-Asp-D-Phe-Cys) TFA Targeting Peptide (CAT#: OLY-1025-YS-68)
- IRGD Peptide 1 TFA (CAT#: OLY-1025-YS-58)
- CSTSMLKAC (disulfide) Targeting Peptide (CAT#: OLY-1025-YS-55)
- Somatostatin-28 (1-14) Targeting Peptide (CAT#: OLY-1025-YS-60)
- GB-6 Targeting Peptide (CAT#: OLY-1025-YS-11)
- CGGK Targeting Peptide (CAT#: OLY-1025-YS-27)
- FFAGLDD Targeting Peptide (CAT#: OLY-1025-YS-43)
- 293P-1 Targeting Peptide (CAT#: OLY-1025-YS-17)
Online Inquiry
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.